I read an interesting interview, on Medscape , with Ann Peters, MD from the University of Southern California .She interviewed Dr. Howard Zisser , the director of clinical research in Diabetes technology at the Sansum Diabetes Research Institute in Santa Barbara, Calif.
The topic was , Artificial Pancreas: Where are we?
The bottom Line;
He predicted that the artificial pancreas will be available in Europe in 2016 and preliminary systems maybe available in the United States by 2018
He mentioned one part of the artificial pancreas is available now , everywhere except the United States, " low glucose suspend " . The insulin pump systems can detect a failure of the user to respond to low glucose warnings and will then suspend insulin delivery for few hours.He expects this to be approved in the United States within the next year. This will be a welcome addition to insulin pump therapy and will reduce the risk of hypoglycemia . I have always been reluctant to recommend insulin pump therapy for anyone living alone . This will also allow moms and dads to sleep a little better when they have a child with Type 1 Diabetes .
Have Fun , Be Smart and enjoy the 4th. of July
The discussion of GPL-1 agonist and DPP-4 inhibitors will resume tomorrow